MDV: Multidose vial; NA: Not available; PFS: Prefilled syringe ... Practices related to predrawing the vaccine into unmarked plastic syringes were observed that could impact patient safety ...

The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun reviewing a prefilled syringe form of Shingrix, GSK's vaccine for shingles ...

The health ministry has secured the wrong syringes for efficient use of Pfizer Inc.’s COVID-19 vaccine, a discovery that could force a review of the inoculation program. A special syringe is ...

GSK (GSK) announced that the US Food and Drug Administration, FDA, has accepted for review the regulatory application of a prefilled syringe presentation ... of the vaccine consists of a ...

GSK plc announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant Zoster Vaccine or RZV) ...

2010 Expert Reviews Ltd. Cite this: Vaccine Presentation in the USA: Economics of Prefilled Syringes versus Multidose Vials for Influenza Vaccination - Medscape - Nov 01, 2010.

4 Over 25 million people in Europe have received GSK’s shingles vaccine since 2018 5 GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the ...